These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7785490)

  • 21. Heterogeneity of type-II interleukin-1 receptors. Heterogeneity of B-cell interleukin-1 binding created by dimerization of type-II interleukin-1 receptors.
    Cronkhite RI; Lobick JJ; Plate JM
    Hum Immunol; 1993 Feb; 36(2):128-36. PubMed ID: 8463123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors.
    Slack J; McMahan CJ; Waugh S; Schooley K; Spriggs MK; Sims JE; Dower SK
    J Biol Chem; 1993 Feb; 268(4):2513-24. PubMed ID: 8428929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta.
    Ambrosetti DC; Palla E; Mirtella A; Galeotti C; Solito E; Navarra P; Parente L; Melli M
    Eur J Biochem; 1996 Jun; 238(2):308-16. PubMed ID: 8681939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A search within the IL-1 type I receptor reveals a peptide with hydropathic complementarity to the IL-1beta trigger loop which binds to IL-1 and inhibits in vitro responses.
    Heal JR; Bino S; Ray KP; Christie G; Miller AD; Raynes JG
    Mol Immunol; 1999 Dec; 36(17):1141-8. PubMed ID: 10698316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional epitope mapping of human interleukin-1 beta by surface plasmon resonance.
    D'Ettorre C; De Chiara G; Casadei R; Boraschi D; Tagliabue A
    Eur Cytokine Netw; 1997 Jun; 8(2):161-71. PubMed ID: 9262965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of type I IL-1 beta receptor fragment 151-162 to interleukin-1 beta.
    Fasina G; Verdoliva A; Cassani G; Melli M
    Growth Factors; 1994; 10(2):99-106. PubMed ID: 8068354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and identification of interleukin-1 receptors on bovine fibroblasts.
    Lederer J; Czuprynski C
    Mol Immunol; 1993 Feb; 30(2):191-6. PubMed ID: 8429834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of small molecule interleukin-1 receptor antagonists based on a benzene template.
    Sarabu R; Cooper JP; Cook CM; Gillespie P; Perrotta AV; Olson GL
    Drug Des Discov; 1998 May; 15(3):191-8. PubMed ID: 9689501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1 beta protein.
    Auron PE; Quigley GJ; Rosenwasser LJ; Gehrke L
    Biochemistry; 1992 Jul; 31(29):6632-8. PubMed ID: 1386253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of soluble type II receptor in the presence of its natural ligand IL-1 beta. Quantification by sandwich ELISA.
    Altenberger EA; Pope HA; Wewers MD
    J Immunol Methods; 1995 Sep; 185(1):115-22. PubMed ID: 7665893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytosolic domain of the type I interleukin-1 receptor spontaneously recruits signaling molecules to activate a proinflammatory gene.
    Singh R; Huang S; Guth T; Konieczkowski M; Sedor JR
    J Clin Invest; 1997 Jul; 100(2):419-28. PubMed ID: 9218520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic C-terminal peptide of IL-1 functions as a binding domain as well as an antagonist for the IL-1 receptor.
    Palaszynski EW
    Biochem Biophys Res Commun; 1987 Aug; 147(1):204-11. PubMed ID: 2958006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detergent solubilization of the interleukin 1 receptor.
    Paganelli KA; Stern AS; Kilian PL
    J Immunol; 1987 Apr; 138(7):2249-53. PubMed ID: 2951435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and biological properties of an interleukin-1 receptor immunoadhesin.
    Pitti RM; Marsters SA; Haak-Frendscho M; Osaka GC; Mordenti J; Chamow SM; Ashkenazi A
    Mol Immunol; 1994 Dec; 31(17):1345-51. PubMed ID: 7997246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation.
    Plugariu CG; Wu SJ; Zhang W; Chaiken I
    Biochemistry; 2000 Dec; 39(48):14939-49. PubMed ID: 11101310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of critical regions within the TIR domain of IL-1 receptor type I.
    Radons J; Falk W; Dove S
    Int J Biochem Cell Biol; 2015 Nov; 68():15-20. PubMed ID: 26279140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human N-terminal analogs of interleukin 1 beta demonstrate altered binding and function in hematopoiesis.
    Zucali JR; Moreb J; Newton RC; Huaog JJ
    Exp Hematol; 1990 Nov; 18(10):1078-82. PubMed ID: 2145179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anion binding and controlled aggregation of human interleukin-1 receptor antagonist.
    Raibekas AA; Bures EJ; Siska CC; Kohno T; Latypov RF; Kerwin BA
    Biochemistry; 2005 Jul; 44(29):9871-9. PubMed ID: 16026159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA.
    Bristulf J; Gatti S; Malinowsky D; Bjork L; Sundgren AK; Bartfai T
    Eur Cytokine Netw; 1994; 5(3):319-30. PubMed ID: 7524717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.